Liquid Biopsy: How Circulating Tumor DNA Is Changing Cancer Monitoring
Liquid biopsy using circulating tumor DNA (ctDNA) is transforming cancer monitoring by detecting tumor changes through a simple blood test. It offers faster, safer insights than tissue biopsies, helping track treatment response and recurrence earlier than scans.
Read More